- Johnson & Johnson
- Genentech Inc.
- Roche Palo Alto
- Bristol-Myers Squibb Co.
- Lederle Laboratories
- Takeda Pharmaceutical Co. Ltd.
- Schwarz Pharma AG
- Kyorin Pharmaceutical Co. Ltd.
- Bayer AG
- BASF SE
- Pharmacia & Upjohn Inc.
- Warner-Lambert Co.
- Adolor Corp.
- Algos Pharmaceutical Corp.
- Anesta Corp.
- Microbot Medical Inc.
- Sicor Inc.
- Northstar Research & Development Ltd.
- Eli Lilly & Co.
- Glaxo Wellcome PLC
- Monsanto Co.
- GD Searle & Co.
- Merck & Co. Inc.
- Wyeth Research
- Zeneca Group PLC
- Takeda Pharma GmbH
- Synaptic Pharmaceutical Corp.
- Noxxon Pharma AG
- Celgene Corp.
- Rockefeller University
- CASI Pharmaceuticals Inc.
- Gruenenthal licenses Kyorin antibiotic AM-1155
- Gruenenthal buys Laboratoire Cipharm
- Roche acquires Syntex for $5.3 billion
- Gruenenthal & Synaptic cooperate in drug search to treat pain
- Warner-Lambert and Synaptic to research galanin receptors
- Noxxon & Gruenenthal in drug discovery deal for chronic pain
- Schwarz Pharma completes IPO, raising $262 million
- Celgene in 2-year R&D agreement with Rockefeller University
Ask The Analyst
Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.